top of page

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Heading 4

Genryzon 60mg Injection

Genryzon 60mg Injection

Manufacturer/Marketed By : PFIZER LTD

$462.54 $323.79

Genryzon 60mg Injection is a long-acting recombinant human growth hormone (GH) analogue used to treat growth hormone deficiency in children and adolescents aged three years and above. This medication promotes...

SOMATROGON

Active Pharmaceutical Ingredient

Genryzon 60mg Injection

SKU GENRYZON-60MG-INJECTION
Original price

$462.54

Sale price

$323.79

Genryzon 60mg Injection is a long-acting recombinant human growth hormone (GH) analogue used to treat growth hormone deficiency in children and adolescents aged three years and above. This medication promotes normal growth by stimulating bone and muscle development and helps maintain a balanced ratio of fat and muscle tissues. It is produced using recombinant DNA technology, where cells are modified in a lab to create the active substance somatrogon. Apart from treating growth deficiencies, Genryzon 60mg Injection Injection aids in improving muscle mass, bone density, and overall body composition. However, it is contraindicated in individuals with severe obesity, active cancer, diabetes, acute critical illness, sleep apnea, hypersensitivity, and other severe conditions. If you or your child experience difficulty breathing, rapid heart rate, swelling, or severe allergic reactions, contact your doctor immediately. Patients with a history of heart problems, diabetes, cancer, or thyroid dysfunction should inform their healthcare provider before starting treatment. It is unknown if Genryzon 60mg Injection affects fertility. Use of this medication during pregnancy is not recommended, and it is advised to consult your doctor if pregnant, planning a pregnancy, or breastfeeding.

Active Pharmaceutical Ingredient

SOMATROGON

Uses

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Benefits

Genryzon 60mg Injection contains the active substance somatrogon, a modified version of the human growth hormone. This hormone is essential for promoting bone and muscle development and regulating the right balance between fat and muscle tissue. By supplementing the body's natural hormone levels, it ensures proper growth in children with GHD.

Side Effects

Very Common (may affect more than 1 in 10 people):

Most Common Side Effects

• Anaemia (reduced red blood cells)
• Eosinophilia (increased eosinophils in the blood)
• Hypothyroidism (low thyroid hormone levels)
• Allergic conjunctivitis (eye inflammation)
• Joint pain (arthralgia) or pain in arms and legs

Common Side Effects

• Headache
• Injection site reactions (such as pain, redness, warmth, or swelling)
• Fever (pyrexia)

How To Use

Genryzon 60mg Injection should be administered once weekly, preferably on the same day each week. The dose can be given at any time of the day, but it is essential to maintain at least 72 hours (3 days) between doses if a change in schedule is necessary.

Safety Advice

• Breast Feeding: It is unclear whether Somtrogon in Genryzon 60mg Injection passes into breast milk. Consult your doctor if you are currently breastfeeding or planning to do so. The decision to either continue or stop treatment will be based on balancing the benefits for both you and your child.
• Alcohol: There is very less information on the interaction between alcohol and Genryzon 60mg Injection. However, it is advised to avoid excessive alcohol consumption during treatment, as it may affect the body’s ability to respond to the medication or worsen certain side effects. Reach out to your healthcare provider if you have any questions or concerns regarding alcohol use while on this medication.
• Liver: The safety and effectiveness of Genryzon 60mg Injection in patients with liver conditions have not been thoroughly studied. If you have any liver issues, consult your doctor to assess the risks before starting treatment.
• Lungs: There is limited information available on the use of Genryzon 60mg Injection in patients with lung conditions. If you or the child in your care have lung-related diseases, discuss with your healthcare provider for appropriate guidance.
• Driving: Genryzon 60mg Injection does not impair the ability to drive or operate machinery.
• Pregnancy: The effects of Genryzon 60mg Injection on unborn babies have not been established, as it has not been studied in pregnant women. It is advisable to avoid this medication during pregnancy unless reliable contraception is used.

Disclaimer

Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.

All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.

Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.

bottom of page